News

Pfizer (NYSE: PFE) is one of the world's largest pharmaceutical companies. It has a long history of innovation and success. Add in a lofty 6.6% dividend yield, and dividend investors are likely to

In some ways, AbbVie (NYSE: ABBV) isn't the same company it was five years ago. Sure, it's still in the biopharmaceuticals business. However, AbbVie has a new CEO. More importantly, it no longer

Shares of AT&T (NYSE: T) jumped more than 10% this past week, according to data from S&P Global Market Intelligence.

The wireless carrier delivered an impressive quarterly financial report and

Last month, millions of people made New Year's resolutions. Many of them have likely already come to a halt. But the experiment I started on Jan. 1 is still going strong, and as the new Voyager

Pfizer (NYSE: PFE) got a huge boost during the coronavirus pandemic thanks to its COVID-19 vaccine. Since that point, however, investors have soured on the stock, which has lost more than half its

Over the past decade, AbbVie (NYSE: ABBV) and Mastercard (NYSE: MA) have produced strong market returns. Their performance is even better once we account for dividends reinvested. That is one of the

John Walter Hanna Jr., President and CEO of CareDx (NASDAQ:CDNA), directly sold 19,480 shares in multiple open-market transactions on Jan. 21 and Jan. 22, 2026, for a total value of approximately

Over the last three years, OpenAI and Anthropic have evolved from speculative artificial intelligence (AI) laboratories into full-blown infrastructure behemoths. Between the two companies, trillions

In the volatile biotech industry, companies can see their shares soar over relatively short periods on strong clinical progress for exciting pipeline candidates.

That's precisely what could happen

Marc Stapley, a director at Glaukos Corporation (NYSE:GKOS), executed a direct sale of 15,000 shares for a transaction value of approximately $1.9 million on Jan. 22, 2026, following the exercise of

In a move that may surprise nobody, artificial intelligence (AI) hyperscalers are planning to double down on their infrastructure spend this year. According to FactSet Research, big tech is forecast

Investors remain extremely upbeat about the outlook for artificial intelligence (AI) stocks, despite fears of an AI bubble. The likely reason is the expectation that these complex computer programs

AbbVie (NYSE: ABBV) is one of the largest pharmaceutical companies in the world. Though its portfolio spans many therapeutic areas, it is particularly well known for its work in immunology, a field

John Hanna, President and CEO of CareDx (NASDAQ:CDNA), directly sold 19,480 shares in multiple open-market transactions on Jan. 21, 2026 and Jan. 22, 2026, with an aggregate transaction value of

David Novack, President & COO of Dynavax Technologies Corporation (NASDAQ:DVAX), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately

Some investors are skeptical of companies with high dividend yields, since it sometimes signals that the dividend may be unsustainable. However, plenty of high-yield dividend stocks look solid

When most people think of artificial intelligence (AI) winners, names like Nvidia or Advanced Micro Devices might come to mind. These are chip designers that are powering key AI tasks like the

Guardant Health (NASDAQ: GH) is on the rise, in more ways than one.

Shares of the precision oncology company have skyrocketed over the last six months. Guardant Health has also chalked up several

AT&T (NYSE:T), a provider of wireless, broadband, and fixed-line telecom services, closed Thursday at $25.11, up 4.32%. The stock moved higher after analyst upgrades and a strong fourth-quarter 2025

Telecom giant AT&T (NYSE: T) agreed to pay $5.75 billion last year to acquire Lumen's fiber business. The deal, which is expected to close early this year, will add 4 million passed locations and 1

Despite a few setbacks, Vertex Pharmaceuticals (NASDAQ: VRTX) performed pretty well last year, although it lagged the S&P 500. However, things could be very different in 2026. Thanks to several

Over the past five years, Novavax (NASDAQ: NVAX), a vaccine maker, lost more than 90% of its market value. Though it succeeded in its goal of launching a coronavirus vaccine, the biotech did so much

Last year, technology outperformed the other 10 sectors of the stock market and the S&P 500, delivering a 24.7% total return. A lot of those gains were driven by semiconductor stocks like Nvidia

The S&P 500 index offers a paltry 1.1% dividend yield. By that standard, even consumer products giant Procter & Gamble's (NYSE: PG) 2.8% yield looks lofty. Here's why dividend lovers may want to

New York City-based Eos Management disclosed a new position in Teleflex (NYSE:TFX) as of December 31, acquiring 30,831 shares in a transaction valued at $3.76 million based on quarter-end pricing.